{"id":54873,"date":"2025-10-21T08:38:23","date_gmt":"2025-10-21T12:38:23","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/novo-nordisk-proposes-lars-rebien-sorensen-as-interim-chair-amidst-board-shake-up\/54873\/"},"modified":"2025-10-21T08:38:23","modified_gmt":"2025-10-21T12:38:23","slug":"novo-nordisk-proposes-lars-rebien-sorensen-as-interim-chair-amidst-board-shake-up","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novo-nordisk-proposes-lars-rebien-sorensen-as-interim-chair-amidst-board-shake-up\/54873\/","title":{"rendered":"Novo Nordisk Proposes Lars Rebien S\u00f8rensen as Interim Chair Amidst Board Shake-Up"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Novo Nordisk A\/S<\/strong> ([NOVO B](\/stock\/NOVO B)) has proposed <strong>Lars Rebien S\u00f8rensen<\/strong> as the new interim Chair of its board of directors, effective until the next Annual General Meeting (AGM).<\/li>\n<li>The nomination follows a significant board overhaul, with current Chair <strong>Helge Lund<\/strong> and six other board members stepping down due to recent market challenges and a decline in the company&#39;s share price since mid-2024.<\/li>\n<li>The <strong>Novo Nordisk Foundation<\/strong>, the majority voting shareholder of Novo Nordisk through <strong>Novo Holdings A\/S<\/strong>, initiated the changes to increase its representation and influence on the board.<\/li>\n<li><strong>Lars Rebien S\u00f8rensen<\/strong> brings extensive experience, having previously served as CEO of Novo Nordisk from 2000 to 2016 and currently chairs the <strong>Novo Nordisk Foundation<\/strong> and <strong>Novo Holdings A\/S<\/strong>.<\/li>\n<\/ul>\n<p>Danish pharmaceutical giant <strong>Novo Nordisk A\/S<\/strong> ([NOVO B](\/stock\/NOVO B)) announced a significant leadership transition, proposing <strong>Lars Rebien S\u00f8rensen<\/strong> as the new interim Chair of its board of directors. The appointment is intended to be temporary, lasting until the company&#39;s next Annual General Meeting. This move comes as the current Chair, <strong>Helge Lund<\/strong>, and six other board members are stepping down, signaling a major shake-up in the company&#39;s governance.<\/p>\n<p>The changes are reportedly a direct response to <em>recent market challenges<\/em> and a <em>notable decline in Novo Nordisk&#39;s share price<\/em> since mid-2024. The <strong>Novo Nordisk Foundation<\/strong>, which controls the majority of voting shares in the company through its investment arm <strong>Novo Holdings A\/S<\/strong>, has actively sought to increase its representation and influence on the board, leading to these executive shifts.<\/p>\n<p><strong>Lars Rebien S\u00f8rensen<\/strong> is a highly experienced figure in the pharmaceutical industry, having served as the President and CEO of <strong>Novo Nordisk A\/S<\/strong> from 2000 to 2016. He currently holds the position of Chair for both the <strong>Novo Nordisk Foundation<\/strong> and <strong>Novo Holdings A\/S<\/strong>, making him a pivotal figure in the broader Novo Group. His deep understanding of the company and the sector is expected to provide stability during this transitional period.<\/p>\n<p>In addition to the board changes, <strong>Lars Fruergaard J\u00f8rgensen<\/strong> will also step down from his role as CEO of <strong>Novo Nordisk A\/S<\/strong>. He has agreed to remain in the position for a transitional period to ensure a smooth handover to his successor, for whom a search is currently underway. The foundation believes these leadership adjustments are in the best interest of the company and its shareholders, aiming to optimally position <strong>Novo Nordisk<\/strong> for future growth and to realize its full potential.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novo Nordisk A\/S ([NOVO B](\/stock\/NOVO B)) has proposed Lars Rebien S\u00f8rensen as the new interim Chair of its [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5227,6334,8412,12864,13167,13168,13169],"class_list":["post-54873","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-healthcare","tag-novo-nordisk","tag-pharmaceutical","tag-agm","tag-lars-rebien-sorensen","tag-board-changes","tag-novo-b"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/54873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=54873"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/54873\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=54873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=54873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=54873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}